Skip to main content

Orthocell gets Remplir approval for Canada

1 day ago

Bookmark

Save articles for future reference.

Shares in Murdoch-based Orthocell rose by 15 per cent early on Wednesday, following news the biotech medical company had received regulatory approval to sell its nerve repair product in Canada.

X

To read our articles you will need to either login or subscribe.